Background: Observational studies have suggested that sodium-glucose cotransporter 2 inhibitors (SGLT2i) are associated with a lower risk of atrial fibrillation (AF) recurrence after catheter ablation ...
Department of Pharmacy, Birla Institute of Technology and Sciences (BITS) Pilani, Hyderabad Campus, Jawahar Nagar, Shameerpet, Hyderabad, Telangana 500078, India ...
The findings of this study support the routine use of sodium-glucose cotransporter 2 (SGLT2) inhibitors to improve kidney outcomes ...
Mediafeed on MSN
Diabetes meds for weight loss, explained by the pros
This article was reviewed by Darragh O’Carroll, MD. Diabetes Medications for Weight Loss: What to Know Key takeaways: Some medications FDA-approved for type 2 diabetes can … ...
Patients with AAV and kidney involvement who take SGLT-2 inhibitors may have a reduced risk for ESRD and kidney transplant ...
CNW/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing a series of novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for inherited cardiac arrhythmias, ...
MedPage Today on MSN
GI Risks Similar Among GLP-1 Drugs, but Higher Than With SGLT-2 Inhibitors
T hree popular GLP-1 receptor agonists carried similar risks for serious gastrointestinal (GI) events among adults with type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback